Evidence map›Paper›PMID 35616332›Full record

ArticlemBio2022

Antibiotic Resistance via Bacterial Cell Shape-Shifting.

Nikola Ojkic, Diana Serbanescu, Shiladitya Banerjee

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. The antimicrobial activity of ETD151 defensin is dictated by the presence of glycosphingolipids in the targeted organisms.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Nikola OjkicDepartment of Physics and Astronomy, Institute for the Physics of Living Systems, University College Londongrid.83440.3b, London, United Kingdom.
Diana SerbanescuDepartment of Physics and Astronomy, Institute for the Physics of Living Systems, University College Londongrid.83440.3b, London, United Kingdom.
Shiladitya BanerjeeDepartment of Physics, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.ORCID 0000-0001-8000-2556
Carnegie Mellon University · USQueen Mary University of London · GBUniversity College London · GB

Funding

Biophysical models and mechanisms for cellular adaptation to environmental stressR35GM143042 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI BANERJEE, SHILADITYA · 2021 to 2025
$1.6M
NIGMS NIH HHS R35 GM143042
6 · The paper itself

Abstract

Bacteria have evolved to develop multiple strategies for antibiotic resistance by effectively reducing intracellular antibiotic concentrations or antibiotic binding affinities, but the role of cell morphology in antibiotic resistance remains poorly understood. By analyzing cell morphological data for different bacterial species under antibiotic stress, we find that bacteria increase or decrease the cell surface-to-volume ratio depending on the antibiotic target. Using quantitative modeling, we show that by reducing the surface-to-volume ratio, bacteria can effectively reduce the intracellular antibiotic concentration by decreasing antibiotic influx. The model further predicts that bacteria can increase the surface-to-volume ratio to induce the dilution of membrane-targeting antibiotics, in agreement with experimental data. Using a whole-cell model for the regulation of cell shape and growth by antibiotics, we predict shape transformations that bacteria can utilize to increase their fitness in the presence of antibiotics. We conclude by discussing additional pathways for antibiotic resistance that may act in synergy with shape-induced resistance.

Indexed as

Anti-Bacterial AgentsBacteriaCell ShapeDrug Resistance, BacterialDrug Resistance, MicrobialAnti-Bacterial Agentsantibiotic resistancebacterial morphogenesisdrug transportgrowth physiologymathematical modeling

Identifiers

PMID35616332
PMCPMC9239207
OpenAlexW4281550888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.